Bulltick Wealth Management, LLC Bio N Tech Se Transaction History

Bulltick Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2024	SELL	$122.57 - $153.67 $294,168 - $368,807	-2,400 Closed	0 $0
Q4 2022 Apr 24, 2024	SELL	$118.43 - $186.05 $7,105 - $11,163	-60 Reduced 2.44%	2,400 $361 Million
Q3 2022 Apr 24, 2024	BUY	$127.65 - $183.11 $314,019 - $450,450	2,460 New	2,460 $332 Million
Q2 2022 Apr 24, 2024	SELL	$123.25 - $186.24 $147,900 - $223,488	-1,200 Closed	0 $0
Q1 2022 Apr 24, 2024	BUY	$126.25 - $231.85 $151,500 - $278,220	1,200 New	1,200 $205 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bulltick Wealth Management, LLC with notifications on news.